• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS PRODUCT GMBH DADE ACTIN FSL ACTIVATED PTT REAGENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS PRODUCT GMBH DADE ACTIN FSL ACTIVATED PTT REAGENT Back to Search Results
Model Number DADE ACTIN FSL ACTIVATED PTT REAGENT
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 03/15/2018
Event Type  malfunction  
Manufacturer Narrative
The customer contacted siemens customer care center (ccc) and reported that an operator misinterpreted the "no coagulation" error as the "flat curve" error and incorrectly reported a flagged activated partial thromboplastin time (aptt) result of <20 seconds.Siemens investigated the issue and determined that quality controls were within expected ranges at the time of the event and correct results were produced by the sysmex cs-2500 systems.Based on the sysmex cs-2500 evaluation and algorithm bulletin, "no coagulation" error is triggered when the system is unable to detect a coagulation reaction or a weak clot was formed.The user should: "check the sample for possible anticoagulant contamination, hemolysis, lipemia, etc; verify delivery of sample and reagent; reanalyze the sample with an extended measurement time (within the range of 100 to 1800 seconds) or set "measurement time (sub)" in the test protocol; if reanalysis with extended time gives "no coagulation" message again, the sample is below the detection limits of the detector.Make a comprehensive judgment, taking sample and reagent, etc.Into consideration.If the result is plausible it may be reported as "greater than" per the established laboratory policy.If additional verification is indicated, use your laboratory policy.If additional verification is indicated, use your laboratory's policy to confirm the data." siemens determined that the customer did not follow the instructions in the sysmex cs-2500 evaluation and algorithm bulletin.The cause of the discordant aptt result reported on a patient sample is a use error.The reagent and systems are performing according to specifications.No further evaluation of these devices is required.
 
Event Description
Non-numerical activated partial thromboplastin time (aptt) results (flagged with "no coagulation") were obtained on three samples from the same patient using the dade actin fsl activated ptt reagent on two sysmex cs-2500 systems.The lab protocol allows the operator to report results flagged with "no coagulation" as greater than the reporting limit as long as the operator reviews the curve and reference the time at 50% as the reportable result.The final result was reported to the physician(s) as <20 seconds and based on this result, the physician(s) restarted the patient's heparin drip at 2 am on (b)(6) 2018.The lab supervisor was made aware of the situation and notified the physician(s), who stopped the patient's heparin drip at 6 am on (b)(6) 2018.On the same day, the patient's blood was redrawn twice and run using the same reagent.The result obtained on the second redrawn sample was reported to the physician(s).There are no known reports of adverse health consequences due to the flagged aptt result reported on the patient sample.
 
Event Description
The final result was reported to the physician(s) as <20.5 seconds, not <20 seconds.
 
Manufacturer Narrative
Additional information (20-apr-2018): the customer provided additional quality control (qc) data for the sysmex cs-2500 system with serial number 22107 and siemens determined that qcs were within expected ranges on both systems on (b)(6) 2018.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DADE ACTIN FSL ACTIVATED PTT REAGENT
Type of Device
DADE ACTIN FSL ACTIVATED PTT REAGENT
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCT GMBH
emil-von-behring-str. 76
marburg, D-350 41
GM  D-35041
MDR Report Key7415170
MDR Text Key105518611
Report Number9610806-2018-00041
Device Sequence Number1
Product Code GGW
UDI-Device Identifier00842768003882
UDI-Public00842768003882
Combination Product (y/n)N
PMA/PMN Number
K863594
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Type of Report Initial,Followup
Report Date 05/16/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/10/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/28/2019
Device Model NumberDADE ACTIN FSL ACTIVATED PTT REAGENT
Device Catalogue Number10445714
Device Lot Number556916
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received04/20/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-